Former Stirling doctor and insulin pioneer wins Pride of Britain prize
A renowned former doctor from Stirling, known for her groundbreaking work in diabetes care and insulin innovation, has been awarded the prestigious Mirror Pride of Britain Lifetime Achievement Award. Sheila Reith, the distinguished honouree, gained recognition for co-inventing the world’s first insulin pen, a device that has greatly improved the lives of diabetes patients globally.
In the late 1970s, Sheila Reith, then a resident of Stirling, faced the challenges of managing her daughter Fiona’s Type 1 diabetes. This personal experience led her to conceptualise a revolutionary insulin pen device that would simplify the process of insulin injections for individuals with diabetes. With determination and a vision to enhance diabetes care, Sheila collaborated with her colleague Dr. John Ireland and bioengineer Dr. John Paton to bring this innovative concept to life.
Despite initial challenges in garnering interest from insulin manufacturers, Sheila, with the support of Diabetes UK and a dedicated team of healthcare professionals, successfully developed and trialled the world’s first commercial insulin pen, Penject, in 1983. Sheila attributes the inspiration for her invention to her daughter Fiona, whose journey with diabetes motivated her to strive for better treatment options. Sheila emphasises the importance of teamwork and acknowledges her colleagues’ contributions to realising her vision.
Following her groundbreaking work in insulin innovation, Sheila expanded her impact at Stirling Royal Infirmary, where she spearheaded initiatives to enhance diabetes care. Collaborating with local GPs, she developed a comprehensive database for diabetes patients, facilitating efficient and personalised healthcare services. Additionally, she championed multidisciplinary care through the establishment of a diabetes education centre that offered holistic support to individuals living with diabetes.
Dr. Reith’s dedication to advancing diabetes care extended beyond medical innovations, as she actively engaged with the community to raise awareness and support for diabetes-related initiatives. Her compassionate approach to patient care and commitment to improving treatment outcomes garnered admiration from colleagues and patients alike. Dr. Elizabeth Robertson of Diabetes UK praised Sheila for her significant contributions to diabetes therapy, which have positively impacted countless individuals battling the condition.
In recognition of her outstanding achievements, Sheila Reith was honoured with a CBE in the King’s Birthday Honours list last year, further underscoring her exceptional contributions to healthcare and diabetes research. As she accepts the Mirror Pride of Britain Lifetime Achievement Award, Sheila reflects humbly on her accomplishments and emphasises the ongoing need for advancements in diabetes research and patient care to benefit individuals living with diabetes.
The commendation of Sheila Reith’s transformative work in diabetes care serves as a testament to her enduring legacy as a pioneer in the field of insulin therapy. Her unwavering commitment to innovation and patient-centric care continues to inspire healthcare professionals and individuals impacted by diabetes worldwide. The recognition of her contributions underscores the importance of collaborative efforts in driving advancements in medical research and improving the quality of life for individuals with chronic conditions like diabetes.